Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
TWST [NASD]
Twist Bioscience Corporation
Healthcare | Diagnostics & Research | USA
statements
Index- P/E- EPS (ttm)-3.76 Insider Own2.40% Shs Outstand44.37M Perf Week0.64%
Market Cap9.46B Forward P/E- EPS next Y-2.61 Insider Trans-37.76% Shs Float42.14M Perf Month25.42%
Income-139.90M PEG- EPS next Q-0.74 Inst Own93.60% Short Float5.97% Perf Quarter121.08%
Sales90.10M P/S104.97 EPS this Y8.90% Inst Trans6.14% Short Ratio3.65 Perf Half Y234.69%
Book/sh7.58 P/B25.15 EPS next Y13.30% ROA-42.30% Target Price116.25 Perf Year774.50%
Cash/sh5.85 P/C32.61 EPS next 5Y- ROE-53.20% 52W Range18.52 - 214.07 Perf YTD34.93%
Dividend- P/FCF- EPS past 5Y- ROI-41.20% 52W High-10.95% Beta-
Dividend %- Quick Ratio9.00 Sales past 5Y- Gross Margin31.80% 52W Low929.37% ATR14.64
Employees525 Current Ratio9.30 Sales Q/Q106.40% Oper. Margin- RSI (14)62.18 Volatility8.96% 9.14%
OptionableYes Debt/Eq0.01 EPS Q/Q42.90% Profit Margin- Rel Volume1.09 Prev Close194.53
ShortableYes LT Debt/Eq0.00 EarningsNov 23 BMO Payout- Avg Volume689.51K Price190.64
Recom2.40 SMA2015.40% SMA5036.77% SMA200146.84% Volume752,754 Change-2.00%
Jan-04-21Downgrade Evercore ISI Outperform → In-line
Oct-20-20Initiated SVB Leerink Mkt Perform $90
May-31-19Initiated Evercore ISI Outperform
Nov-26-18Initiated JP Morgan Neutral $27
Jan-20-21 11:28AM  
A Deep Dive into ARK ETFs
Zacks
Jan-19-21 08:00AM  
Twist Bioscience Signs Two Biopharma Technology Agreements to Enable Novel Therapeutics Discovery
Business Wire +13.31%
Jan-14-21 12:27PM  
Want to Use ETFs to Play Biotech? Choose Wisely.
Barrons.com +12.48%
08:00AM  
Twist Bioscience Begins Shipping of Synthetic RNA Controls for UK Variant Strain of SARS-CoV-2
Business Wire
Jan-11-21 05:12PM  
SKB finalizes new lease agreement with Twist Bioscience Corporation ("Twist") at recently repositioned mixed-use campus, ParkWorks Industrial Center
PR Newswire
Jan-07-21 08:00AM  
Twist Bioscience Supplies Centers for Disease Control and Prevention with Custom SARS-CoV-2 Synthetic RNA Controls
Business Wire +9.45%
Jan-04-21 08:00AM  
Twist Bioscience to Present at the 39th Annual J.P. Morgan Healthcare Conference
Business Wire -5.92%
Dec-31-20 05:00AM  
The Best Stock Picker of 2020 Wins With Disruptive DNA
Bloomberg
Dec-23-20 08:00AM  
Twist Bioscience to Offer Synthetic RNA Control for UK Variant Strain of SARS-CoV-2
Business Wire
Dec-22-20 08:00AM  
Twist Bioscience to Expand Commercial Capabilities with Factory of the Future
Business Wire +10.45%
Dec-21-20 06:42PM  
How a Relentless Dealmaker Cracked Silicon Valleys Bros Club
Bloomberg
Dec-18-20 10:20PM  
Is TWST A Good Stock To Buy Now According To Hedge Funds?
Insider Monkey
Dec-10-20 08:00AM  
Twist Bioscience Expands Gene Product Line with Launch of Clonal-Ready Gene Fragments
Business Wire +8.17%
Dec-07-20 04:05PM  
Twist Bioscience Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares
Business Wire
Dec-02-20 08:34PM  
Twist Bioscience Announces Pricing of a $300 Million Upsized Public Offering of Common Stock
Business Wire
Dec-01-20 04:01PM  
Twist Bioscience Announces Proposed Public Offering of Common Stock
Business Wire +5.69%
Nov-26-20 02:15AM  
Earnings Update: Here's Why Analysts Just Lifted Their Twist Bioscience Corporation (NASDAQ:TWST) Price Target To US$110
Simply Wall St.
Nov-24-20 08:00AM  
Twist Bioscience to Present at Upcoming Virtual Investor Conferences
Business Wire -11.11%
Nov-23-20 06:00PM  
Twist Bioscience Corp (TWST) Q4 2020 Earnings Call Transcript
Motley Fool
07:54AM  
Twist Bioscience: Q4 Earnings Insights
Benzinga
07:01AM  
Twist Bioscience Reports Fourth Quarter and Full Year Fiscal 2020 Financial Results
Business Wire
07:00AM  
Twist Bioscience Announces Positive Preclinical Data for SARS-CoV-2 Antibodies
Business Wire
06:15AM  
Twist Bioscience Corp. to Host Earnings Call
ACCESSWIRE
Nov-20-20 10:04AM  
Earnings Preview for Twist Bioscience
Benzinga
Nov-19-20 08:00AM  
Twist Bioscience and Biotia Announce Research Use Only Availability of First Hybridization Capture-Based Next-Generation Sequencing SARS-CoV-2 Assay for Characterization and Surveillance of the Virus
Business Wire
Nov-18-20 08:00AM  
Twist Bioscience Ranked 60th Fastest Growing Company in North America on Deloittes 2020 Fast 500
Business Wire
Nov-16-20 12:30PM  
Will Twist Bioscience (TWST) Report Negative Earnings Next Week? What You Should Know
Zacks
08:00AM  
Twist Bioscience Expands Infectious Disease Product Line Adding Comprehensive Viral Panel
Business Wire
07:59AM  
Twist Bioscience Continues Support for Next Generation of Synthetic Biologists Through Work with iGEM Competition
Business Wire
Nov-12-20 03:15PM  
Twist Bioscience, Illumina and Western Digital Form Alliance with Microsoft to Advance Data Storage in DNA
Business Wire
Nov-10-20 08:00AM  
Twist Bioscience to Present at the Stifel 2020 Virtual Healthcare Conference
Business Wire
Nov-02-20 08:00AM  
Twist Bioscience to Report Fiscal 2020 Fourth Quarter and Full Year Financial Results on Monday, November 23, 2020
Business Wire
Oct-29-20 08:00AM  
Twist Bioscience Showcases Next-Generation Sequencing Presentations at Virtual American Society for Human Genetics 2020 Annual Meeting
Business Wire
Oct-27-20 08:00AM  
Twist Bioscience Collaborates With Beyond Earth to Launch Artwork Stored in DNA Into Space
Business Wire
Oct-20-20 09:56AM  
Benzinga's Top Upgrades, Downgrades For October 20, 2020
Benzinga
Oct-13-20 03:03PM  
Hedge Funds Cant Stop Buying Twist Bioscience Corporation (TWST)
Insider Monkey
08:00AM  
Twist Bioscience to Host Virtual Biopharma Analyst & Investor Event on October 23, 2020
Business Wire
07:00AM  
Twist Bioscience and Neogene Announce Broad Strategic Partnership for Next Generation Personalized T Cell Therapies
Business Wire
Sep-18-20 08:00AM  
Emily Leproust, Ph.D., to Receive 2020 Rosalind Franklin Award
Business Wire
Sep-16-20 01:38PM  
Shareholders Are Thrilled That The Twist Bioscience (NASDAQ:TWST) Share Price Increased 107%
Simply Wall St.
Sep-03-20 08:00AM  
Twist Bioscience to Present at Upcoming Virtual Investor Conferences
Business Wire
Sep-02-20 08:00AM  
Twist Bioscience Announces Potent SARS-CoV-2 Neutralizing Data from COVID-19 Therapeutic Antibody Program
Business Wire
Aug-20-20 08:00AM  
Twist Bioscience Synthetic DNA Stores New Netflix Original Series BIOHACKERS
Business Wire
Aug-13-20 10:35AM  
Twist Bioscience Is Rapidly Growing Its Customer Base. Can It Turn a Profit?
Motley Fool
Aug-06-20 07:10PM  
Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue Estimates
Zacks
04:05PM  
Twist Bioscience Reports Third Quarter Fiscal 2020 Financial Results
Business Wire
Aug-04-20 08:00AM  
Seismic Bio Partners With Twist Bioscience for Discovery and Optimization of Antibodies
Business Wire +5.61%
Jul-30-20 12:34PM  
Will Twist Bioscience (TWST) Report Negative Q3 Earnings? What You Should Know
Zacks
08:00AM  
Twist Bioscience to Report Fiscal 2020 Third Quarter Financial Results on Thursday, August 6, 2020
Business Wire
Jul-28-20 08:00AM  
Twist Bioscience Launches Two SARS-CoV-2 Antibody Panels to Expedite Research for COVID-19
Business Wire
Jul-23-20 08:00AM  
Twist Bioscience Appoints Erin Smith Senior Vice President, Government Affairs and Public Policy
Business Wire
Jul-22-20 08:21AM  
Twist Bioscience Has Gained 186% in 2020. Is the Synbio Stock a Buy?
Motley Fool
08:00AM  
Twist Bioscience Launches Synthetic Controls for Respiratory Viruses
Business Wire
Jul-16-20 08:00AM  
Twist Bioscience Partners with Invetx to Deliver Best-in-Class Antibody Therapeutics for Dogs and Cats
Business Wire -5.43%
Jul-15-20 02:20PM  
Twist Bioscience Customer Vanderbilt University Medical Center (VUMC) Announces Publication of Positive Preclinical Results on Neutralizing Antibodies as a Potential Therapy for Preventing and Treating COVID-19
Business Wire
Jul-08-20 08:00AM  
Takeda Partners with Twist Bioscience to Expand Biologics Discovery Capabilities
Business Wire +11.82%
Jul-01-20 08:12AM  
The Daily Biotech Pulse: T2 Biosystems Launches COVID-19 Test, Akero Aces Midstage NASH Study, Aravive Added to Russell Indexes
Benzinga
Jun-30-20 08:00AM  
Twist Bioscience Adds Respiratory Virus Panel to Infectious Disease Product Line
Business Wire +7.83%
Jun-28-20 05:23PM  
Hedge Funds Keep Buying Twist Bioscience Corporation (TWST)
Insider Monkey
Jun-11-20 08:00AM  
Twist Bioscience Expands Offering of Synthetic SARS-CoV-2 RNA Controls
Business Wire -7.57%
Jun-09-20 08:30AM  
Twist Bioscience Partners with Serimmune to Identify SARS-CoV-2 Therapeutic Antibody Candidates
PR Newswire
Jun-08-20 04:05PM  
Twist Bioscience Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares
Business Wire
Jun-03-20 10:16PM  
Twist Bioscience Announces Pricing of a $100 Million Public Offering of Common Stock
Business Wire
04:27PM  
Twist Bioscience Announces Proposed Public Offering of Common Stock
Business Wire
Jun-01-20 08:00AM  
Twist Bioscience to Join Proteona in Global Alliance to Protect Immunocompromised Patients From COVID-19 Infection
Business Wire +5.40%
May-26-20 08:00AM  
Twist Bioscience to Present at the Jefferies Virtual Healthcare Conference
Business Wire -5.15%
May-17-20 04:15PM  
Schrodinger Shares Have More Than Tripled Since IPO
GuruFocus.com
May-12-20 08:00AM  
Twist Bioscience to Participate in the UBS Virtual Global Healthcare Conference
Business Wire
May-08-20 05:30PM  
Twist Bioscience Corp (TWST) Q2 2020 Earnings Call Transcript
Motley Fool +6.71%
May-07-20 08:10PM  
Twist Bioscience (TWST) Reports Q2 Loss, Tops Revenue Estimates
Zacks
04:05PM  
Twist Bioscience Reports Second Quarter Fiscal 2020 Financial Results
Business Wire
May-06-20 08:00AM  
Twist Bioscience Identifies Competitive Antibodies for SARS-CoV-2
Business Wire +10.31%
Apr-30-20 08:00AM  
Twist Bioscience to Report Fiscal 2020 Second Quarter Financial Results on Thursday, May 7, 2020
Business Wire
Apr-28-20 12:33PM  
Twist Bioscience (TWST) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
Zacks
Apr-20-20 08:30AM  
Twist Bioscience's Shares March Higher, Can It Continue?
Zacks
08:00AM  
Twist Bioscience Expands Flexibility of Clonal Genes for Pharmaceutical, Biotechnology and Industrial Chemical Research
Business Wire
Apr-13-20 10:55AM  
Why Twist Bioscience (TWST) Stock Might be a Great Pick
Zacks
Mar-26-20 08:00AM  
Twist Bioscience Partners with Vanderbilt University Medical Center to Supply Critical Products and Identify Antibody Therapeutics for COVID-19
Business Wire +9.01%
Mar-25-20 08:00AM  
Twist Bioscience Synthetic SARS-CoV-2 RNA Controls Added to FDA Website as Reference Materials
Business Wire
Mar-24-20 04:23PM  
Biotech stocks have held up better than the broader market and these five are potential winners
MarketWatch +10.68%
Mar-16-20 08:00AM  
Twist Announces Availability of Next-Generation Sequencing Target Enrichment Panel for SARS-CoV-2/COVID-19 Research
Business Wire -22.85%
Mar-12-20 08:00AM  
Twist Bioscience Announces Availability of Synthetic SARS-CoV-2 RNA Controls
Business Wire -14.68%
Feb-26-20 08:05AM  
Twist Bioscience and SOPHiA GENETICS Collaborate to Offer Optimized Genomic Solutions
Business Wire
08:00AM  
Twist Bioscience to Present at the Cowen 40th Annual Health Care Conference
Business Wire
Feb-25-20 08:00AM  
Twist Bioscience and Miroculus Agree to Collaborate on Next-Generation Sequencing Target Enrichment and Library Preparation Tools for Clinical Research
Business Wire
Feb-24-20 04:05PM  
Twist Bioscience Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares
Business Wire
08:00AM  
Twist Bioscience Launches New NGS Solutions, Highlights Customers at 2020 Advances in Genome Biology and Technology Conference
Business Wire
06:00AM  
GenapSys Partners With Twist Bioscience to Bring Next-Generation Sequencing Target Enrichment and Library Preparation to Worlds Most Accessible Highly Accurate Sequencer
Business Wire
Feb-19-20 07:51PM  
Twist Bioscience Announces Pricing of Upsized $130.0 Million Public Offering of Common Stock
Business Wire -6.94%
Feb-18-20 04:11PM  
Twist Bioscience Announces Proposed Public Offering of Common Stock
Business Wire
Feb-12-20 08:00AM  
Twist Bioscience Now ISO 27001:2013 Certified for Information Security Management System
Business Wire
Feb-06-20 02:30PM  
Twist Bioscience Corp. to Host Earnings Call
ACCESSWIRE +16.30%
07:47AM  
The Daily Biotech Pulse: Tonix Slumps On Failed Study, Applied Genetic Announces Offering, Beam Therapeutics, PPD Price IPOs
Benzinga
Jan-31-20 04:18PM  
CORRECTING and REPLACING Twist Bioscience Announces Completion of $50 Million Offering Priced At-The-Market
Business Wire
Jan-23-20 11:26AM  
Inovio Selected by CEPI to Develop Vaccine Against New Coronavirus
PR Newswire
09:15AM  
Inovio Selected by CEPI to Develop Vaccine Against New Coronavirus
PR Newswire
08:00AM  
Twist Bioscience to Report Fiscal 2020 First Quarter Financial Results on Thursday, February 6, 2020
Business Wire
Jan-15-20 12:00PM  
Twist Bioscience Selected as DNA Synthesis Provider for DNA Data Storage Project Under Intelligence Advanced Research Projects Activity (IARPA) Molecular Information Storage (MIST) Program
Business Wire +9.40%
08:00AM  
Twist Bioscience Announces Strategic Collaboration With Schrödinger for Drug Discovery
Business Wire
Jan-13-20 08:00AM  
Twist Bioscience Promotes Patrick Weiss to Chief Operating Officer Setting Stage for Future Growth
Business Wire
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has a collaboration agreement with ImmunoPrecise Antibodies Ltd. Twist Bioscience Corporation was founded in 2013 and is headquartered in South San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Leproust Emily M.President & CEOJan 20Sale209.735,0001,048,636396,196Jan 21 04:30 PM
Leproust Emily M.President & CEOJan 19Sale200.4120,0004,008,132401,196Jan 21 04:30 PM
Leproust Emily M.President & CEOJan 14Sale184.3410,0001,843,356421,196Jan 19 05:02 PM
Leproust Emily M.President & CEOJan 12Sale166.882,000333,751431,196Jan 14 04:30 PM
Finn Patrick JohnChief Commercial OfficerJan 05Option Exercise23.282,70262,89546,930Jan 07 04:50 PM
Finn Patrick JohnChief Commercial OfficerJan 05Sale132.932,702359,17744,228Jan 07 04:50 PM
Daniels MarkSee RemarksJan 04Option Exercise10.706697,15869,303Jan 05 05:52 PM
Daniels MarkSee RemarksJan 04Sale138.6166992,73068,634Jan 05 05:52 PM
Daniels MarkSee RemarksDec 31Option Exercise26.661,16631,08669,953Jan 05 05:52 PM
Daniels MarkSee RemarksDec 31Sale152.131,166177,38468,787Jan 05 05:52 PM
Daniels MarkSee RemarksDec 28Option Exercise8.823773,32569,164Dec 29 05:53 PM
Daniels MarkSee RemarksDec 28Sale167.1037762,99768,787Dec 29 05:53 PM
Daniels MarkSee RemarksDec 24Option Exercise23.3362014,46569,407Dec 29 05:53 PM
Leproust Emily M.President & CEODec 24Option Exercise5.955,30031,535433,959Dec 28 08:00 PM
Daniels MarkSee RemarksDec 24Sale167.79620104,03068,787Dec 29 05:53 PM
Leproust Emily M.President & CEODec 23Sale169.315,000846,531428,659Dec 28 08:00 PM
Leproust Emily M.President & CEODec 22Sale160.125,000800,583433,659Dec 23 04:33 PM
Daniels MarkSee RemarksDec 21Option Exercise9.6712,451120,39368,787Dec 23 04:32 PM
Leproust Emily M.President & CEODec 21Sale150.3310,0001,503,336438,659Dec 22 05:31 PM
Leproust Emily M.President & CEODec 18Sale144.992,000289,972448,659Dec 22 05:31 PM
Daniels MarkSee RemarksDec 15Option Exercise18.1168,8441,246,597126,811Dec 17 07:25 PM
Banyai WilliamSee RemarksDec 15Sale132.6620,0002,653,185476,440Dec 17 07:27 PM
Green PaulaSVP of Human ResourcesDec 15Sale139.734,634647,50922,804Dec 17 07:26 PM
Leproust Emily M.President & CEODec 15Sale134.2470,0009,396,516450,659Dec 17 07:26 PM
Daniels MarkSee RemarksDec 15Sale132.6770,4759,350,20556,336Dec 17 07:25 PM
Weiss PatrickChief Operating OfficerDec 14Option Exercise24.6240,000984,82594,350Dec 16 05:47 PM
Weiss PatrickChief Operating OfficerDec 14Sale144.0040,0005,760,16154,350Dec 16 05:47 PM
Weiss PatrickChief Operating OfficerDec 11Option Exercise8.713,55830,99457,773Dec 14 05:42 PM
Weiss PatrickChief Operating OfficerDec 11Sale151.133,558537,72154,350Dec 14 05:42 PM
Weiss PatrickChief Operating OfficerDec 10Option Exercise8.713,55030,93557,769Dec 14 05:42 PM
THORBURN JAMES MChief Financial OfficerDec 10Option Exercise15.1120,000302,14669,718Dec 14 05:43 PM
THORBURN JAMES MChief Financial OfficerDec 10Sale149.1120,0182,984,89049,700Dec 14 05:43 PM
Weiss PatrickChief Operating OfficerDec 10Sale138.623,550492,10154,350Dec 14 05:42 PM
Finn Patrick JohnChief Commercial OfficerDec 07Option Exercise21.1325,845546,14170,267Dec 09 04:30 PM
CRANDELL KEITHDirectorDec 07Sale103.4075,0007,755,000288,104Dec 09 05:11 PM
Finn Patrick JohnChief Commercial OfficerDec 07Sale131.4625,8453,397,58244,422Dec 09 04:30 PM
Banyai WilliamSee RemarksNov 30Sale113.652,790317,084496,440Dec 02 04:25 PM
Weiss PatrickChief Operating OfficerNov 13Option Exercise8.713,55030,93558,997Nov 16 05:39 PM
Weiss PatrickChief Operating OfficerNov 13Sale107.203,550380,56055,578Nov 16 05:39 PM
Weiss PatrickChief Operating OfficerNov 12Option Exercise8.713,55030,93558,997Nov 16 05:39 PM
Weiss PatrickChief Operating OfficerNov 12Sale102.903,550365,29555,578Nov 16 05:39 PM
Weiss PatrickChief Operating OfficerOct 09Option Exercise8.713,55030,93560,118Oct 13 04:09 PM
Weiss PatrickChief Operating OfficerOct 09Sale86.633,550307,53756,699Oct 13 04:09 PM
Weiss PatrickChief Operating OfficerOct 08Option Exercise8.713,55030,93560,118Oct 13 04:09 PM
Weiss PatrickChief Operating OfficerOct 08Sale89.583,550318,00956,699Oct 13 04:09 PM
Weiss PatrickChief Operating OfficerSep 18Option Exercise8.713,55030,93560,118Sep 21 04:58 PM
Weiss PatrickChief Operating OfficerSep 18Sale65.213,550231,49656,699Sep 21 04:58 PM
Weiss PatrickChief Operating OfficerSep 17Option Exercise8.713,55030,93567,689Sep 21 04:58 PM
Weiss PatrickChief Operating OfficerSep 17Sale60.7511,121675,60156,699Sep 21 04:58 PM
Green PaulaVP of Human ResourcesSep 16Option Exercise6.9226,988186,82546,458Sep 18 05:08 PM
Green PaulaVP of Human ResourcesSep 16Sale63.3726,9881,710,10028,615Sep 18 05:08 PM
THORBURN JAMES MChief Financial OfficerSep 09Option Exercise26.6620,000533,20071,719Sep 11 04:13 PM
THORBURN JAMES MChief Financial OfficerSep 09Sale65.9620,0001,319,12451,719Sep 11 04:13 PM
THORBURN JAMES MChief Financial OfficerSep 08Option Exercise13.8770,000970,876111,130Sep 09 06:03 PM
THORBURN JAMES MChief Financial OfficerSep 08Sale63.0870,0004,415,79051,719Sep 09 06:03 PM
Leproust Emily M.President & CEOSep 08Sale60.353,482210,156607,698Sep 09 06:04 PM
THORBURN JAMES MChief Financial OfficerSep 04Option Exercise11.5930,000347,70081,719Sep 09 06:03 PM
THORBURN JAMES MChief Financial OfficerSep 04Sale63.5830,0001,907,30951,719Sep 09 06:03 PM
Leproust Emily M.President & CEOSep 04Sale63.0896,5186,088,154611,180Sep 09 06:04 PM
Finn Patrick JohnChief Commercial OfficerAug 31Option Exercise8.822,35820,79838,748Sep 02 04:41 PM
Finn Patrick JohnChief Commercial OfficerAug 27Sale67.222,358158,49536,390Aug 31 07:11 PM
Daniels MarkSee RemarksAug 17Option Exercise5.9520,994124,91474,712Aug 18 06:52 PM
Daniels MarkSee RemarksAug 17Sale68.0720,9941,429,09853,718Aug 18 06:52 PM
Daniels MarkSee RemarksAug 14Option Exercise5.959,00653,58662,724Aug 17 04:24 PM
Daniels MarkSee RemarksAug 14Sale66.179,006595,90253,718Aug 17 04:24 PM
Daniels MarkSee RemarksAug 13Option Exercise5.9514,50286,28768,220Aug 17 04:24 PM
Daniels MarkSee RemarksAug 13Sale64.5314,502935,83853,718Aug 17 04:24 PM
Leproust Emily M.President & CEOAug 07Sale69.9814,000979,786689,055Aug 11 04:26 PM
Finn Patrick JohnChief Commercial OfficerJul 31Option Exercise8.822,35820,79839,097Aug 04 04:46 PM
Finn Patrick JohnChief Commercial OfficerJul 31Option Exercise8.822,35820,79839,097Aug 04 04:42 PM
Finn Patrick JohnChief Commercial OfficerJul 23Sale59.112,358139,37536,739Jul 27 05:31 PM
Leproust Emily M.President & CEOJul 21Sale59.3315,000889,967703,055Jul 22 05:48 PM
Banyai WilliamSee RemarksJul 16Sale53.1211,000584,282493,592Jul 17 06:10 PM
Banyai WilliamSee RemarksJul 15Sale55.6111,000611,694504,592Jul 17 06:10 PM
Finn Patrick JohnChief Commercial OfficerJul 08Option Exercise26.6628,820768,34139,097Jul 10 06:45 AM
Banyai WilliamSee RemarksJul 08Sale53.1525,0001,328,793515,592Jul 10 04:15 PM
Leproust Emily M.President & CEOJul 08Sale50.3719,700992,289718,055Jul 10 06:44 AM
Leproust Emily M.President & CEOJul 07Sale49.0030014,700737,755Jul 10 06:44 AM
Finn Patrick JohnChief Commercial OfficerJul 07Sale47.1116,084757,65810,277Jul 10 06:45 AM
Finn Patrick JohnChief Commercial OfficerJul 06Sale46.6911,336529,27126,361Jul 08 05:52 PM
Finn Patrick JohnChief Commercial OfficerJul 02Sale46.681,40065,35437,697Jul 07 08:05 PM
Finn Patrick JohnChief Commercial OfficerJun 25Option Exercise8.828417,41839,097Jun 29 06:05 PM
Daniels MarkSee RemarksJun 16Option Exercise5.953,53621,03957,254Jun 17 05:18 PM
Banyai WilliamSee RemarksJun 16Sale38.7511,000426,204540,592Jun 17 05:18 PM
Daniels MarkSee RemarksJun 16Sale38.803,536137,18153,718Jun 17 05:18 PM
Green PaulaVP of Human ResourcesJun 15Option Exercise5.9516,833100,15639,448Jun 17 05:17 PM
Banyai WilliamSee RemarksJun 15Sale38.1511,000419,607551,592Jun 17 05:18 PM
Green PaulaVP of Human ResourcesJun 15Sale38.0016,833639,65422,615Jun 17 05:17 PM
Daniels MarkSee RemarksJun 10Sale40.001,96278,48053,718Jun 11 06:42 PM
Weiss PatrickChief Operating OfficerJun 08Sale37.2520,000744,94057,606Jun 10 04:44 PM
Leproust Emily M.President & CEOJun 01Sale39.1424,500958,888738,055Jun 03 05:03 PM
Banyai WilliamSee RemarksJun 01Sale40.0120,113804,641562,592Jun 03 05:04 PM
Finn Patrick JohnChief Commercial OfficerMay 29Option Exercise8.828417,41838,256Jun 01 06:27 PM
Finn Patrick JohnChief Commercial OfficerMay 28Sale37.092,11678,48537,415Jun 01 06:27 PM
Finn Patrick JohnChief Commercial OfficerMay 26Option Exercise38.464,207161,80139,531May 28 07:44 PM
Leproust Emily M.President & CEOMay 26Sale39.0710,593413,827762,555May 27 06:26 PM
Leproust Emily M.President & CEOMay 22Sale39.2714,513569,923773,148May 27 06:26 PM
Leproust Emily M.President & CEOMay 21Sale39.5414,438570,852787,661May 22 09:07 PM
Banyai WilliamSee RemarksMay 21Sale40.034,887195,629582,705May 22 09:07 PM
Leproust Emily M.President & CEOMay 20Sale39.7540,9561,627,811805,106May 22 09:07 PM
open in yahoo | open in reuters | open in google
affiliate • advertise • contact • privacy • help
Do not sell my personal information
Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2021 FINVIZ.com. All Rights Reserved.